US 9388164
Methods of using pyruvate kinase activators
granted A61KA61K31/397A61K31/4427
Quick answer
US patent 9388164 (Methods of using pyruvate kinase activators) held by Agios Pharmaceuticals, Inc. expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/397, A61K31/4427, A61K31/4725, A61P